19-19539772-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_153221.2(CILP2):āc.158G>Cā(p.Trp53Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000202 in 1,587,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_153221.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000389 AC: 9AN: 231650Hom.: 0 AF XY: 0.0000238 AC XY: 3AN XY: 126158
GnomAD4 exome AF: 0.0000125 AC: 18AN: 1434972Hom.: 0 Cov.: 31 AF XY: 0.0000126 AC XY: 9AN XY: 712046
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74348
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.158G>C (p.W53S) alteration is located in exon 2 (coding exon 2) of the CILP2 gene. This alteration results from a G to C substitution at nucleotide position 158, causing the tryptophan (W) at amino acid position 53 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at